News
Zacks.com on MSN13h
JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?
JNJ edges out AZN following Q2 results with raised guidance, stronger estimate revisions and a more attractive valuation.
Zacks.com on MSN7h
3 Medical Stocks to Consider as Markets Take a Breather
These top medical stocks may be able to provide defensive safety after President Trump's tariff hikes and July's unfavorable ...
Shares of European pharmaceutical companies sold off on Friday after President Donald Trump issued letters to 17 companies, ...
24/7 Wall St. on MSN9h
4 Very Safe Dividend Stocks on Goldman Sachs’ August Conviction Buy List
Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 35th on the Fortune 500 ...
Explore market-impacting Trump administration moves, from drug pricing reforms targeting pharma giants to Swiss tariff hikes.
Pharmaceutical stocks slumped after President Donald Trump sent letters to 17 drugmakers with an ultimatum to reduce drug ...
Shares of European drugmakers slipped on Friday after U.S. President Donald Trump sent letters to major pharmaceutical firms to cut drug prices in the United States, months after signing a sweeping ...
Investing.com - Shares of European drugmakers fell on Friday after President Donald Trump issued letters to more than a dozen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback